Outsourced Pharma Webinars
-
Cell Therapy Milestones, Challenges, And Forming The Future Of TILs
8/15/2023
What milestones enabled the evolution of TIL therapies? What does the future hold for TIL therapies? And where should you focus support for an accelerated path forward? Watch to explore these topics and more.
-
Capabilities And Opportunities Of Innovative Cell Processing System In CGT
8/15/2023
Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.
-
Best Practices Under ICH E14/S7B For Non-Clinical, Clinical Strategies
8/14/2023
Scientific experts discuss how the ICH E14/S7B (Q&As) in vitro hERG and in vivo QT assays will be conducted, interpreted, and reported.
-
Digital Pathology And Machine Learning
8/14/2023
Learn how digital pathology can advance non-clinical pathology workflows and expand opportunities to improve study outcomes with increased speed and flexibility, data quality, and communication pathways.
-
Direct CNS Delivery Of Oligonucleotides: Beware Of The Unexpected
8/14/2023
As we gain more experience in the CNS ASO administration field, we are beginning to see unexpected scenarios arising despite using “well-understood” oligonucleotide backbones.
-
Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS
8/11/2023
Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.
-
Maximizing The Value Of Your AAV Using Small Volume AAV Testing
8/11/2023
Learn about MilliporeSigma's approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.
-
Solutions For Sustainable Chemistry And Supply Chain
7/31/2023
Examine how a CRDMO committed to delivering innovative solutions can help meet the unique needs and requirements of clients in the pharmaceutical, biotechnology, and other industries.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
7/26/2023
To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.
-
The Role Of PUPSIT In A Contamination Control Strategy
7/25/2023
Here, we discuss the relationship between the CCS and PUPSIT, highlight the role of sterilizing grade filtration in the control strategy, and talk about how this can change throughout the product life cycle.